AU5200699A - Inhibition of lipoprotein formation - Google Patents

Inhibition of lipoprotein formation

Info

Publication number
AU5200699A
AU5200699A AU52006/99A AU5200699A AU5200699A AU 5200699 A AU5200699 A AU 5200699A AU 52006/99 A AU52006/99 A AU 52006/99A AU 5200699 A AU5200699 A AU 5200699A AU 5200699 A AU5200699 A AU 5200699A
Authority
AU
Australia
Prior art keywords
inhibition
lipoprotein formation
lipoprotein
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52006/99A
Inventor
Sally Priscilla Anna McCormick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Otago
Original Assignee
University of Otago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Otago filed Critical University of Otago
Publication of AU5200699A publication Critical patent/AU5200699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
AU52006/99A 1998-07-13 1999-07-13 Inhibition of lipoprotein formation Abandoned AU5200699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ33096698 1998-07-13
NZ330966 1998-07-13
PCT/NZ1999/000109 WO2000002920A1 (en) 1998-07-13 1999-07-13 Inhibition of lipoprotein formation

Publications (1)

Publication Number Publication Date
AU5200699A true AU5200699A (en) 2000-02-01

Family

ID=19926827

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52006/99A Abandoned AU5200699A (en) 1998-07-13 1999-07-13 Inhibition of lipoprotein formation

Country Status (2)

Country Link
AU (1) AU5200699A (en)
WO (1) WO2000002920A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (en) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptides from apolipoprotein B, use thereof immunization, method of diagnosis or therapeutic treatment of ischemic cardiovascular diseases, and pharmaceutical composition and vaccine containing such peptide
MXPA04002848A (en) 2001-09-28 2005-06-06 Esperion Therapeutics Inc Prevention and treatment of restenosis by local administration of drug.
SE0302312D0 (en) 2002-10-04 2003-08-27 Forskarpatent I Syd Ab Peptide-based passive immunization therapy for the treatment of atherosclerosis
WO2005097206A2 (en) 2004-04-06 2005-10-20 Cedars-Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
CN103501806A (en) 2010-11-12 2014-01-08 赛达斯西奈医疗中心 Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
EP2637689A2 (en) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors

Also Published As

Publication number Publication date
WO2000002920A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
EP1143953A3 (en) Method of inhibiting angiogenesis
AU5100599A (en) Egf-genistein for prevention of restenosis
PL341397A1 (en) Inhibition of lipoprotein oxidation
AU7839198A (en) Method of laminate formation
AU6007699A (en) Showerhead
IL137540A0 (en) Inhibitors of phospholipase a2
AU3300599A (en) Per-method designation of security requirements
AU1271297A (en) Inhibitor of ceramidase
AU6229699A (en) Beta-amyloid formation inhibitors
AUPP303498A0 (en) Inhibition of gram positive bacteria
AU3091599A (en) Method of making dimethylnaphtalenes
AU1488501A (en) Methods of inhibiting metastasis
AU6150498A (en) Methods and compositions for the inhibition of interleukin-12 production
AU2277597A (en) New inhibitors of sh2-mediated processes
AU4971199A (en) Oligonucleotide inhibitors of bcl-xl
AU5673099A (en) Inhibitors of amyloid formation
AU5200699A (en) Inhibition of lipoprotein formation
AU1287100A (en) Peptide inhibitor of browman-birk type
AU7715300A (en) Method of preventing osteoporosis
AU4369000A (en) Inhibition of complement action
AU4440199A (en) Methods and compositions for inhibition of angiogenesis
AU5126298A (en) Inhibition of crib-biting
AU4288399A (en) Manufacture of boxes
AU9119998A (en) Method of time-to-talk calculation
AU4700197A (en) Corrosion inhibition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase